Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
复制标题
DOI:
10.1093/annonc/mdt354
复制
发表时间:
2013-10-01
影响因子:
50.5
通讯作者:
Arnold, D.
中科院分区:
文献类型:
--
作者:
Labianca, R.;Nordlinger, B.;Arnold, D.
Colorectal cancer (CRC) is the third most common tumour in men and the second in women, accounting for 10% of all tumour types worldwide. Incidence is higher in males (ratio: 1.4) and for both genders there is a 10-fold difference in incidence between several regions. With 608 000 deaths estimated each year (∼ 8% of all cancer deaths), CRC is the fourth most common cancer-related cause of death in the world [1].As a general observation, there has been an increasing incidence in countries where the overall risk of large bowel cancer was low, while in historically high-risk countries either a stabilisation (Western Europe and Australia) or a decrease (USA, Canada and New Zealand) in incidence was reported [2]. A gradient of incidence and mortality between North Western and South Eastern Europe has been observed: new CRC cases increased in historically low-risk areas such as Spain and Eastern Europe [3]. This growing incidence reflects modifications in lifestyle behaviours and their consequences related with ‘westernisation’such as obesity, physical inactivity, heavy alcohol consumption, high red meat consumption and smoking.